Cellcyte Genetics Corp. Proceeds from Common Stock Issued
Cellcyte Genetics Corp. reported Proceeds from Common Stock Issued of $6.66 million for the 12-month period ending 2013-03-31, per its 10-Q filed 2013-05-15.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfCommonStock · last filed 2013-05-15
- Cellcyte Genetics Corp. proceeds from issuance of common stock for the quarter ending 2011-09-30 was $6.66M.
- Cellcyte Genetics Corp. proceeds from issuance of common stock for the quarter ending 2011-06-30 was $6.66M.
| Period end | Proceeds from Issuance of Common Stock 3 month | Proceeds from Issuance of Common Stock 6 month | Proceeds from Issuance of Common Stock 12 month | Proceeds from Issuance of Common Stock 48 month | Proceeds from Issuance of Common Stock 81 month |
|---|---|---|---|---|---|
| 2013-03-31 | $6.66M 10-Q · filed 2013-05-15 | ||||
| 2012-12-31 | $6.66M 10-K · filed 2013-04-12 | ||||
| 2012-09-30 | $6.66M 10-Q · filed 2012-11-14 | ||||
| 2012-06-30 | $6.66M 10-Q · filed 2012-08-14 | ||||
| 2012-03-31 | $6.66M 10-Q · filed 2012-05-15 | ||||
| 2011-12-31 | $6.66M 10-K · filed 2012-04-16 | ||||
| 2011-09-30 | $6.66M 10-Q · filed 2011-11-08 | $13.31M derived: sum of 2 quarters · filed 2011-11-08 | $6.66M 10-Q · filed 2011-11-08 | ||
| 2011-06-30 | $6.66M 10-Q · filed 2011-08-15 |